The CDTI Innovation invests, together with PARTNERS, in ASABYS ALLOX, company that develops a technology for the identification of sites in key proteins alostéricos
The CDTI innovation, through its programme Innvierte, together with PARTNERS, SGEIC ASABYS, SA, has reached an agreement with the partners of ALLOSTERY EXPLORATION TECHNOLOGIES, S.L. (hereinafter ALLOX), to enter the capital of the company
ALLOXis a company spin-off techbio, the centre of regulation Genomics (CRG) of Barcelona. The company develops a technological platform, which combines biology and computer technology, to identify sites in protein alostéricos relevant to the treatment of diseases. The discovery of these new sites alostéricos will pave the way for the design and development of new drugs, more focused and targeted.
The platform ALLOX is based on the multidimensional mutagénesis "", a pilot approach developed in the laboratory of Ben Lehner, measuring the activity of up to 1 million versions mutants of a protein in a single experiment. The method can be directly linked genetic changes with measurements and phenotypic biophysical, unprecedented. This method enables the company to scan, at the sequence of proteins, and identify new pockets alostéricas. Unlike other methodologies, is scalable, rapid and cost-effective way. Furthermore, the unprecedented scale of biophysical measurements that resulted from the experimental platform ALLOX will lay the foundations for the development of IA algorithms to expand the development efforts of drugs.
Initially ALLOX focuses on proteins that are key to the treatment of cancer, but the platform has the potential to be applied in many other diseases.
Asabys Partners
Asabys Partnersit is a venture capital firm specialized in the health sector, founded in 2018 by Josep Ll. Sanfeliu and clear, shared by Campàs Alantra and with the support of Banc Sabadell as anchor. Asabys investor invests in innovative companies and disruptive covering medical needs not covered in the vertical biofarma and health. The investment of the signing in ALLOX comes from their vehicles Sabadell Asabys Health Innovation Investments II, RCF and Sabadell Asabys Health Innovation Investments 2B, SCR SA. This operation has been supported by the european union under the Invest EU Fund.
CDTI Innovation
The CDTI innovation is the public funding of innovation of the ministry of science, innovation and universities that promotes innovation and technological development of spanish companies, channeling requests for funding and support for r & D & I projects of spanish entities at the state and international levels. We Contribute to the improvement of the technological level of spanish companies and drive and, with an international network with coverage of 51 countries support the spanish participation in international programmes for technology cooperation and the international transfer of technology.
Additionally, through the initiative Innvierte Sustainable Economy, supports and facilitates the capitalization of technology companies. Since 2012 and to date, the CDTI Innovation, through Innvierte, has committed more than us $955 M €in 32 investment vehicles that have invested in more than 270 companies, and through its joint investment line directly committed an amount of more than 485 M €in at least 152 companies.
More information:
Office of the press
prensa@cdti.es
91-581.55.00
On The Internet
Website:www.cdti.es
In Linkedin:https :// www.linkedin.com/company/29815
X:https :// twitter.com/CDTI _ innovation
On Youtube:https :// www.youtube.com/user/CDTIoficial
This content is copyright © 2024 CDTI, Soes. Permitted for use and reproduction by quoting the source and digital identity of CDTI (@CDTI _ innovation).